Journal of Applied Pharmaceutical Research
Vol. 14 No. 5 (2026)

Advanced respiratory drug delivery systems from nanocarriers to intelligent inhalation technologies: revolutionizing pulmonary therapeutics

Gargi Sawant (Department of Pharmaceutics, D. Y. Patil Deemed to be University, School of Pharmacy, Nerul East, Navi Mumbai – 400706, Maharashtra, India)
Archana Barhate (Department of Pharmaceutics, D. Y. Patil Deemed to be University, School of Pharmacy, Nerul East, Navi Mumbai – 400706, Maharashtra, India)



Article Info

Publish Date
31 Oct 2026

Abstract

Background: Respiratory drug delivery systems (RDDS) are important for treating respiratory and systemic diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Pulmonary administration offers rapid drug action, targeted delivery, and avoidance of first-pass metabolism. Methodology: This review examines recent developments in RDDS, emphasizing nanotechnology-based systems such as liposomes, solid lipid nanoparticles (SLNs), and polymeric nanoparticles. The review also discusses conventional inhalation devices, including nebulizers, dry powder inhalers (DPIs), and metered-dose inhalers (MDIs). The review covers key factors affecting delivery, including particle size, aerosol dynamics, device design, mucociliary clearance, and enzymatic degradation. The authors also consider formulation and manufacturing approaches such as micronization and spray drying. Results and Discussion: Nanotechnology-based carriers offer potential advantages, including sustained drug release and improved pulmonary delivery. RDDS have applications in respiratory and infectious diseases, lung cancer, pulmonary hypertension, and inhaled vaccines and gene therapy. The review also highlights challenges related to formulation development, manufacturing, inhalation systems, and patient inhalation technique. Effective pulmonary delivery depends on appropriate formulation characteristics, aerosol behavior, device performance, and physiological conditions. These factors can influence drug deposition and therapeutic effectiveness. Conclusion: Advances in nanocarrier-based and inhalation technologies are expanding the potential of pulmonary therapeutics. Further development of effective formulations, scalable manufacturing methods, and patient-friendly inhalation systems may support improved pulmonary drug delivery.

Copyrights © 2026






Journal Info

Abbrev

joapr

Publisher

Subject

Medicine & Pharmacology

Description

Journal of Applied Pharmaceutical Research (JOAPR) is an official publication of Creative Pharma Assent (CPA). It is an open access, peer review online international journal. JOAPR is primarily focused on multiple discipline of pharmaceutical sciences (Pharmaceutics, Pharmaceutical Technology, ...